Nobivac Respira Bb offers protection against a significant cause for Canine Infectious Respiratory Disease (commonly referred to as kennel cough) in the UK’s first injectable vaccine against Bordetella bronchiseptica. It is recommended for any dogs that regularly socialise or are kennelled with other dogs (e.g. boarding, dog training) where intranasal vaccination with Nobivac® KC is not the preferred or appropriate method. Dogs at risk of this whooping cough-like syndrome benefit from vaccination against this very common and widespread threat.
Aqueous, white to nearly white, mild creaming suspension for subcutaneous injection.
Nobivac Respira Bb is an inactivated subunit bacterin vaccine.
Per 1 ml dose vaccine:
88 - 399 U1 Bordetella bronchiseptica fimbriae2
1 Antigenic mass ELISA units
2 Purified from strain Bb7 92932
Also contains dl-α-tocopheryl acetate as an adjuvant and thiomersal as an excipient.
Indications for use
For the active immunisation of dogs against Bordetella bronchiseptica to reduce clinical signs of upper respiratory tract disease and bacterial shedding post infection.
Cardboard box with 1 multidose PET vial containing 10 doses (10 ml) of vaccine with a rubber stopper and aluminium cap.
For full information please refer to the product data sheet. Further information is available on request.
If you are not the prescribing veterinary surgeon, advice should be sought from the medicine prescriber.
Use Medicines Responsibly.
Date of preparation: February 2021